Bo-Cheng
Huang
a,
Yun-Chi
Lu
bc,
Jun-Min
Liao
bc,
Hui-Ju
Liu
d,
Shih-Ting
Hong
d,
Yuan-Chin
Hsieh
e,
Chih-Hung
Chuang
cf,
Huei-Jen
Chen
d,
Tzu-Yi
Liao
d,
Kai-Wen
Ho
d,
Yeng-Tseng
Wang
*h and
Tian-Lu
Cheng
*abcg
aInstitute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan. E-mail: tlcheng@kmu.edu.tw
bDepartment of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
cDrug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan
dGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
eSchool of Medicine for International Students, I-Shou University, Kaohsiung, Taiwan
fDepartment of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan
gDepartment of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
hDepartment of Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan. E-mail: c00jsw00@kmu.edu.tw
First published on 20th July 2021
Correction for ‘Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies’ by Bo-Cheng Huang et al., Chem. Sci., 2021, DOI: 10.1039/D1SC01748A.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |